SEC Form 4 · accession 0001179110-17-008216
MEDICINES CO /DE · MDCO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Armin M Kessler
Director
Period of report
May 25, 2017
Accepted (ET)
May 30, 2017 · 7:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001113481
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 25, 2017 | A | 3,237 | $0.00 | A | 150,993 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right-to-buy)F2 | $39.39 | May 25, 2017 | A | 8,577 | A | — | May 25, 2027 | Common Stock | 8,577 | 8,577 | D |
Explanation of responses
- F1This restricted stock award vests on May 25, 2018 and is made as part of and pursuant to Issuer's director compensation package.
- F2This option vests in one installment on May 25, 2018 and is made as part of and pursuant to Issuer's director compensation package.